文献速递呼吸道感染肺结节与肺癌慢阻肺

肺部超声在真实临床环境下呼吸系统疾病诊断流程中的价值:一项多中心前瞻性研究

Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study.
PubMed 文献 · Respirology · 2019-08-02

该多中心前瞻性研究纳入509例因呼吸相关症状入院的连续患者,评估肺部超声(LUS)在呼吸系统疾病诊断流程中的作用,并与胸部X线(CXR)比较准确性。以CT诊断为金标准,LUS与CXR的ROC曲线下面积、敏感性和特异性差异显著(P=0.001),LUS与最终诊断一致(P<0.0001),健康患者假阳性率低(5.9%)。结果支持LUS在临床常规使用。

要点

  • LUS诊断准确性优于CXR,ROC曲线下面积差异显著(P=0.001)。
  • LUS与最终诊断一致(P<0.0001),健康者假阳性率仅5.9%。
  • 最终诊断以肺炎最常见(240例,47.2%)。

核心结论

  • 结果支持肺部超声在临床环境中常规使用。

研究设计与样本

  • 多中心前瞻性研究,历时2年,纳入509例因呼吸相关症状入住急诊和普通内科病房的连续患者。
  • 患者均接受肺部超声(LUS)和胸部X线(CXR)检查,LUS由对病史和实验室数据不知情的专家操作。
  • CXR与LUS不一致、怀疑肺癌或诊断不明确时行胸部CT,以CT诊断为金标准。

主要发现

  • LUS与CXR的ROC曲线下面积、特异性和敏感性差异显著(P=0.001):LUS-AUROC 0.853,特异性81.6%,敏感性93.9%;CXR-AUROC 0.763,特异性57.4%,敏感性96.3%。
  • 最终诊断包括肺炎240例(47.2%)、癌症44例(8.6%)、慢阻肺20例(3.9%)、心力衰竭24例(4.7%)及其他(6.1%)。
  • 108例(21.2%)存在肺部病变的患者行CT扫描,96例(88.9%)获得阳性诊断;其中CXR和LUS分别有24例(25%)和5例(5.2%)未检测到异常。
  • LUS与最终诊断一致(P<0.0001),健康患者中假阳性率低(5.9%)。

临床怎么用

  • 在呼吸系统疾病诊断流程中可常规使用LUS,其准确性优于CXR。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The aim of this study was to assess the role of lung ultrasound (LUS) in a diagnostic algorithm of respiratory diseases, and to establish the accuracy of LUS compared with chest radiography (CXR). METHODS: Over a period of 2 years, 509 consecutive patients admitted for respiratory-related symptoms to both emergency and general medicine wards were enrolled and evaluated using LUS and CXR. LUS was conducted by expert operators who were blinded to the medical history and laboratory data. Computed tomography (CT) of the chest was performed in case of discordance between the CXR and LUS, suspected lung cancer and an inconclusive diagnosis. Diagnosis made by CT was considered the gold standard. RESULTS: The difference in sensitivity and specificity between LUS and CXR as demonstrated by ROC curve analyses (LUS-AUROC: 0.853; specificity: 81.6%; sensitivity: 93.9% vs CXR-AUROC: 0.763; specificity: 57.4%; sensitivity: 96.3%) was significant (P = 0.001). Final diagnosis included 240 cases (47.2%) of pneumonia, 44 patients with cancer (8.6%), 20 patients with chronic obstructive pulmonary disease (COPD, 3.9%), 24 patients with heart failure (4.7%) and others (6.1%). In 108 patients (21.2%) with any lung pathology, a CT scan was performed with a positive diagnosis in 96 cases (88.9%); we found that CXR and LUS detected no abnormality in 24 (25%) and 5 (5.2%) cases, respectively. LUS was concordant with the final diagnosis (P < 0.0001), and in healthy patients, there was a low percentage of false positives (5.9%). CONCLUSION: The results support the routine use of LUS in the clinical context.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Rinaldi L, Milione S, Fascione MC, et al. Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study. Respirology. 2019. PMID: 31373748. doi:10.1111/resp.13659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。